Kura Oncology KURA Proceeds from issuance of common stock relating to employee stock plans
Proceeds from issuance of common stock relating to employee stock plans at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's proceeds from issuance of common stock relating to employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's proceeds from issuance of common stock relating to employee stock plans?
- Kura Oncology (KURA) reported proceeds from issuance of common stock relating to employee stock plans of $69K in Q1 2026.
- How has Kura Oncology's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
- Kura Oncology's proceeds from issuance of common stock relating to employee stock plans decreased by 51.7% year-over-year, from $143K to $69K.
- What is the long-term trend for Kura Oncology's proceeds from issuance of common stock relating to employee stock plans?
- Over 2 years (2022 to 2025), Kura Oncology's proceeds from issuance of common stock relating to employee stock plans has grown at a -36.3% compound annual growth rate (CAGR), from $4.42M to $1.79M.